HR 5381
116th Congress
House
Health
Consumer affairs
Drug safety, medical device, and laboratory regulation
Prescription drugs
International Pharmaceutical Transparency Act of 2019
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 11, 2019
Referred to the Subcommittee on Health.
Dec 10, 2019
Referred to the House Committee on Energy and Commerce.
Dec 10, 2019
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
International Pharmaceutical Transparency Act of 2019
This bill prohibits the sale of a drug if its label fails to list the country of origin of each of the drug's active ingredients.
What's happening now
Referred to the Subcommittee on Health.
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
2
Cite this page
U.S. Congress. (2026). H.R. 5381: International Pharmaceutical Transparency Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-5381/
"H.R. 5381: International Pharmaceutical Transparency Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-5381/.
H.R. 5381, 116th Cong. (2026), https://openamerica.io/bill/116-HR-5381/.
[H.R. 5381: International Pharmaceutical Transparency Act of 2019](https://openamerica.io/bill/116-HR-5381/)